AstraZeneca PLC revenue for the last year amounted to 54.07 B USD, the most of which — 20.27 B USD — came from its highest performing source at the moment, Oncology, the year earlier bringing 17.14 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought AstraZeneca PLC 21.81 B USD, and the year before that — 18.12 B USD.